Literature DB >> 27987693

Poly(lactic acid) nanoparticles loaded with ursolic acid: Characterization and in vitro evaluation of radical scavenging activity and cytotoxicity.

Emilli Antônio1, Osmar Dos Reis Antunes1, Isis Souza de Araújo1, Najeh Maissar Khalil1, Rubiana Mara Mainardes2.   

Abstract

The purpose of this study was to develop poly(lactic acid) (PLA) nanoparticles containing ursolic acid (UA) by an emulsification-solvent evaporation technique and evaluate the radical scavenging activity over hypochlorous acid (HOCl) and cytotoxicity over erythrocytes and tumor cells. Nanoparticles were successfully obtained and presented mean size of 246nm with spherical or slightly oval morphology, negative zeta potential and 96% of UA encapsulation efficiency. Analyses of FTIR, XRD and DSC-DTG suggest interaction/complexation of UA with PLA matrix and drug amorphization promoted by nanoencapsulation process. Stability study showed that room temperature was the best condition for nanoparticles storage. The in vitro release study showed UA was released from the polymeric matrix over two constants (α, β), suggesting a second order kinetics. After 120h of assay, 60% of UA were released by diffusion. In the HOCl scavenging activity, after 72h of assay UA-loaded nanoparticles presented the same efficacy of free drug. In cytotoxicity test over red blood cells, UA-loaded nanoparticles showed less toxicity on cells than free drug. The cytotoxicity assay over melanoma cells line (B16-F10) showed after 72h that nanoparticles were able to reduce the cell viability in 70%. PLA nanoparticles showed be potential carriers for UA maintaining the antioxidant and antitumor activity of the UA and decreasing its cytotoxicity over normal cells.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; HOCl; Nanoparticles; Poly(lactic acid); Stability; Ursolic acid

Mesh:

Substances:

Year:  2016        PMID: 27987693     DOI: 10.1016/j.msec.2016.09.080

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  4 in total

1.  Ursolic acid protects against cisplatin‑induced ototoxicity by inhibiting oxidative stress and TRPV1‑mediated Ca2+‑signaling.

Authors:  Yang Di; Tao Xu; Yuan Tian; Tingting Ma; Donghao Qu; Yan Wang; Yuhan Lin; Dongyan Bao; Li Yu; Shuangyue Liu; Aimei Wang
Journal:  Int J Mol Med       Date:  2020-06-04       Impact factor: 4.101

Review 2.  Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule.

Authors:  Longyun Wang; Qianqian Yin; Cun Liu; Ying Tang; Changgang Sun; Jing Zhuang
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

Review 3.  Nanoantioxidants: Recent Trends in Antioxidant Delivery Applications.

Authors:  Ibrahim Khalil; Wageeh A Yehye; Alaitz Etxabide Etxeberria; Abeer A Alhadi; Seyedehsara Masoomi Dezfooli; Nurhidayatullaili Binti Muhd Julkapli; Wan Jefrey Basirun; Ali Seyfoddin
Journal:  Antioxidants (Basel)       Date:  2019-12-26

Review 4.  Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Authors:  Jingwei Shao; Yifan Fang; Ruirui Zhao; Fangmin Chen; Mingyue Yang; Jiali Jiang; Zixuan Chen; Xiaotian Yuan; Lee Jia
Journal:  Asian J Pharm Sci       Date:  2020-03-21       Impact factor: 6.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.